Therapeutic Potential of Combined Herbal Medicine and Electroacupuncture in Mild Cognitive Impairment Through Cytokine Modulation: An Observational Study

References

• Chen P, Cai H, Bai W, et al. Global prevalence of mild cognitive impairment among older adults living in nursing homes: a meta-analysis and systematic review of epidemiological surveys. Transl Psychiatry. 2023;13(1):88. doi:10.1038/s41398-023-02361-1
   PubMed Web of Science ®Google Scholar
• Lee JS, Kang MJ, Lee O, Lee H, Kwak M, Yu W. Korean Dementia Observatory; 2022:1–175.
   Google Scholar
• Chehrehnegar N, Nejati V, Shati M, et al. Early detection of cognitive disturbances in mild cognitive impairment: a systematic review of observational studies. Psychogeriatrics. 2020;20:212–228.
   PubMed Web of Science ®Google Scholar
• Wang W, Diwu Y, Liu Q, et al. Chinese herbal medicine for mild cognitive impairment using Mini-Mental State Examination: a systematic review and meta-analysis. Medicine. 2021;100(38):e27034. doi:10.1097/MD.0000000000027034
   PubMed Web of Science ®Google Scholar
• Jongsiriyanyong S, Limpawattana P. Mild cognitive impairment in clinical practice: a review article. Am J Alzheimers Dis Other Demen. 2018;33(8):500–507. doi:10.1177/1533317518791401
   PubMed Web of Science ®Google Scholar
• Xiang Y, Bu XL, Liu YH, et al. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer’s disease. Acta Neuropathol. 2015;130(4):487–499. doi:10.1007/s00401-015-1477-1
   PubMed Web of Science ®Google Scholar
• Wang J, Gu BJ, Masters CL, Wang Y-J. A systemic view of Alzheimer disease – insights from amyloid-beta metabolism beyond the brain. Nat Rev Neurol. 2017;13(10):612–623. doi:10.1038/nrneurol.2017.111
   PubMed Web of Science ®Google Scholar
• Deng T. Syndrome differentiation and treatment: an essence of traditional Chinese medicine. Tradit Chin Med J. 2005;1:1–4.
   Google Scholar
• Liang N, Chen Y, Yang S, et al. Chinese herbal medicine for mild cognitive impairment: a systematic review of randomized controlled trials. Front Neurol. 2022;13:903224. doi:10.3389/fneur.2022.903224
   PubMedGoogle Scholar
• Choi Y, Kim YE, Jerng UM, et al. Korean traditional medicine in treating patients with mild cognitive impairment: a multicenter prospective observational case series. Evid Based Complement Alternat Med. 2020;2020:4323989. doi:10.1155/2020/4323989
   PubMed Web of Science ®Google Scholar
• Cao J, Huang Y, Meshberg N, Hodges SA, Kong J. Neuroimaging-based scalp acupuncture locations for dementia. J Clin Med. 2020;9(8):2477. doi:10.3390/jcm9082477
   PubMed Web of Science ®Google Scholar
• Kim H, Kim HK, Kim SY, Kim YI, Yoo HR, Jung IC. Cognitive improvement effects of electro-acupuncture for the treatment of MCI compared with Western medications: a systematic review and meta-analysis. BMC Complement Altern Med. 2019;19(1):13. doi:10.1186/s12906-018-2407-2
   PubMedGoogle Scholar
• Shin HY, Kim HR, Jahng GH, et al. Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial. BMC Complement Med Ther. 2021;21(1):251. doi:10.1186/s12906-021-03428-6
   PubMedGoogle Scholar
• Ishida K. Effect of donepezil and kamikihito combination therapy on cognitive function in Alzheimer’s disease: retrospective study. Trad Kampo Med. 2016;3(2):94–99. doi:10.1002/tkm2.1045
   Google Scholar
• Cho SY, Kwon S, Shin HY, et al. Treatment evaluation of Kami Guibi-tang on participants with amnestic mild cognitive impairment using magnetic resonance imaging on brain metabolites, gamma-aminobutyric acid, and cerebral blood flow. J Appl Clin Med Phys. 2021;22(11):151–164. doi:10.1002/acm2.13443
   PubMed Web of Science ®Google Scholar
• Choi Y, Kim AR, Lee JY, et al. Herbal medicine for patients with cognitive impairment: an observational study. Neuropsychiatr Dis Treat. 2021;17:3183–3194. doi:10.2147/NDT.S333569
   PubMed Web of Science ®Google Scholar
• Yang Y, Li S, Huang H, et al. Comparison of the protective effects of ginsenosides Rb1 and Rg1 on improving cognitive deficits in SAMP8 mice based on anti-neuroinflammation mechanism. Front Pharmacol. 2020;11:834. doi:10.3389/fphar.2020.00834
   PubMed Web of Science ®Google Scholar
• Mook-Jung I, Hong HS, Boo JH, et al. Ginsenoside Rb1 and Rg1 improve spatial learning and increase hippocampal synaptophysin level in mice. J Neurosci Res. 2001;63(6):509–515. doi:10.1002/jnr.1045
   PubMed Web of Science ®Google Scholar
• Zhao C, Zhang H, Li H, et al. Geniposide ameliorates cognitive deficits by attenuating the cholinergic defect and amyloidosis in middle-aged Alzheimer model mice. Neuropharmacology. 2017;116:18–29. doi:10.1016/j.neuropharm.2016.12.002
   PubMed Web of Science ®Google Scholar
• Zhou Y, Luo D, Shi J, et al. Loganin alleviated cognitive impairment in 3×Tg-AD mice through promoting mitophagy mediated by optineurin. J Ethnopharmacol. 2023;312:116455. doi:10.1016/j.jep.2023.116455
   PubMed Web of Science ®Google Scholar
• Lee Y, Gao Q, Kim E, et al. Pretreatment with 5-hydroxymethyl-2-furaldehyde blocks scopolamine-induced learning deficit in contextual and spatial memory in male mice. Pharmacol Biochem Behav. 2015;134:57–64. doi:10.1016/j.pbb.2015.04.007
   PubMed Web of Science ®Google Scholar
• Hopkins AL. Network pharmacology. Nat Biotechnol. 2007;25(10):1110–1111. doi:10.1038/nbt1007-1110
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhu X, Bai H, Ning K. Network pharmacology databases for Traditional Chinese Medicine: review and assessment. Front Pharmacol. 2019;10:123. doi:10.3389/fphar.2019.00123
   PubMed Web of Science ®Google Scholar
• Chang Z, Wang YC, Tian D, et al. Medication rules in herbal medicine for mild cognitive impairment: a network pharmacology and data mining study. Evid Based Complement Alternat Med. 2022;2022:2478940. doi:10.1155/2022/2478940
   PubMed Web of Science ®Google Scholar
• Sachs-Ericsson N, Blazer DG. The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment. Aging Mental Health. 2015;19(1):2–12. doi:10.1080/13607863.2014.920303
   PubMed Web of Science ®Google Scholar
• Lee JY, Dong Woo L, Cho SJ, et al. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol. 2008;21(2):104–110. doi:10.1177/0891988708316855
   PubMed Web of Science ®Google Scholar
• Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x
   PubMed Web of Science ®Google Scholar
• Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci. 2009;10(6):434–445. doi:10.1038/nrn2639
   PubMed Web of Science ®Google Scholar
• Nielsen MG, Ørnbøl E, Vestergaard M, et al. The construct validity of the Perceived Stress Scale. J Psychosom Res. 2016;84:22–30.
   PubMed Web of Science ®Google Scholar
• Mirza SS, Ikram MA, Bos D, Mihaescu R, Hofman A, Henning Tiemeier H. Mild cognitive impairment and risk of depression and anxiety: a population-based study. Alzheimers Dement. 2017;13(2):130–139. doi:10.1016/j.jalz.2016.06.2361
   PubMed Web of Science ®Google Scholar
• Cerri LQ, Justo MC, Clemente V, Gomes AA, Pereira AS, Marques DR. Insomnia Severity Index: a reliability generalisation meta-analysis. J Sleep Res. 2023;32:e13835.
   PubMed Web of Science ®Google Scholar
• Brownlow JA, Miller KE, Gehrman PR. Insomnia and cognitive performance. Sleep Med Clin. 2020;15(1):71–76. doi:10.1016/j.jsmc.2019.10.002
   PubMed Web of Science ®Google Scholar
• Wilson MM, Thomas DR, Rubenstein LZ, et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82(5):1074–1081. doi:10.1093/ajcn/82.5.1074
   PubMed Web of Science ®Google Scholar
• Oh SY, Koh SJ, Baek JY, et al. Validity and reliability of Korean version of Simplified Nutritional Appetite Questionnaire in patients with advanced cancer: a multicenter, longitudinal study. Cancer Res Treat. 2019;51:1612–1619.
   PubMed Web of Science ®Google Scholar
• Feng YS, Kohlmann T, Janssen MF, Buchholz I. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res. 2021;30(3):647–673. doi:10.1007/s11136-020-02688-y
   PubMed Web of Science ®Google Scholar
• Lee SW, Lyu YR, Kim SY, et al. Efficacy and safety of GHX02 in the treatment of acute bronchitis and acute exacerbation of chronic bronchitis: a Phase II, randomized, double-blind, placebo-controlled, multicenter trial. Front Pharmacol. 2021;12:761575.
   PubMed Web of Science ®Google Scholar
• Gokhman D, Kelman G, Amartely A, Gershon G, Tsur S, Carmel L. Gene ORGANizer: linking genes to the organs they affect. Nucleic Acids Res. 2017;45:W138–W145.
   PubMed Web of Science ®Google Scholar
• Brosseron F, Krauthausen M, Kummer M, Heneka MT. Body fluid cytokine levels in mild cognitive impairment and Alzheimer’s disease: a comparative overview. Mol Neurobiol. 2014;50(2):534–544. doi:10.1007/s12035-014-8657-1
   PubMed Web of Science ®Google Scholar
• Saresella M, Calabrese E, Marventano I, et al. Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer’s disease. Brain Behav Immun. 2011;25:539–547.
   PubMed Web of Science ®Google Scholar
• Serre-Miranda C, Roque S, Santos NC, et al. Cognition is associated with peripheral immune molecules in healthy older adults: a cross-sectional study. Front Immunol. 2020;11:2045. doi:10.3389/fimmu.2020.02045
   PubMed Web of Science ®Google Scholar
• Jeong JY, Chung YC, Jin BK. Interleukin-4 and interleukin-13 exacerbate neurotoxicity of prothrombin kringle-2 in cortex in vivo via oxidative stress. Int J Mol Sci. 2019;20(8):1927. doi:10.3390/ijms20081927
   PubMed Web of Science ®Google Scholar
• Francos-Quijorna I, Amo-Aparicio J, Martinez-Muriana A, López-Vales R. IL-4 drives microglia and macrophages toward a phenotype conducive for tissue repair and functional recovery after spinal cord injury. Glia. 2016;64(12):2079–2092. doi:10.1002/glia.23041
   PubMed Web of Science ®Google Scholar
• Xie L, Zhang N, Zhang Q, et al. Inflammatory factors and amyloid β-induced microglial polarization promote inflammatory crosstalk with astrocytes. Aging. 2020;12(22):22538–22549. doi:10.18632/aging.103663
   PubMedGoogle Scholar
• Eom TM, Kwon HH, Shin N, et al. Traditional Korean herbal formulae, Yuk-Mi-Ji-Hwang-Tang, ameliorates impairment of hippocampal memory ability by chronic restraint stress of mouse model. J Ethnopharmacol. 2020;260:113102. doi:10.1016/j.jep.2020.113102
   PubMed Web of Science ®Google Scholar
• Liu B, Chen B, Yi J, et al. Liuwei dihuang decoction alleviates cognitive dysfunction in mice with D-galactose-induced aging by regulating lipid metabolism and oxidative stress via the microbiota-gut-brain axis. Front Neurosci. 2022;16:949298. doi:10.3389/fnins.2022.949298
   PubMed Web of Science ®Google Scholar
• Scarabino D, Peconi M, Broggio E, et al. Relationship between proinflammatory cytokines (IL-1beta, IL-18) and leukocyte telomere length in mild cognitive impairment and Alzheimer’s disease. Exp Gerontol. 2020;136:110945. doi:10.1016/j.exger.2020.110945
   PubMed Web of Science ®Google Scholar
• Rui W, Xiao H, Fan Y, et al. Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer’s disease. J Neuroinflammation. 2021;18(1):280. doi:10.1186/s12974-021-02329-2
   PubMed Web of Science ®Google Scholar
• Su C, Zhao K, Xia H, Xu Y. Peripheral inflammatory biomarkers in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis. Psychogeriatrics. 2019;19(4):300–309. doi:10.1111/psyg.12403
   PubMed Web of Science ®Google Scholar
• Kann O, Almouhanna F, Chausse B. Interferon γ: a master cytokine in microglia-mediated neural network dysfunction and neurodegeneration. Trends Neurosci. 2022;45(12):913–927. doi:10.1016/j.tins.2022.10.007
   PubMed Web of Science ®Google Scholar
• Belkhelfa M, Rafa H, Medjeber O, et al. IFN-γ and TNF-α are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients. J Interferon Cytokine Res. 2014;34(11):839–847. doi:10.1089/jir.2013.0085
   PubMed Web of Science ®Google Scholar
• Yin Z, Herron S, Silveira S, et al. Identification of a protective microglial state mediated by miR-155 and interferon-γ signaling in a mouse model of Alzheimer’s disease. Nat Neurosci. 2023;26(7):1196–1207. doi:10.1038/s41593-023-01355-y
   PubMed Web of Science ®Google Scholar
• Mayagoitia K, Tolan AJ, Shammi S, et al. Loss of APP in mice increases thigmotaxis and is associated with elevated brain expression of IL-13 and IP-10/CXCL10. Physiol Behav. 2021;240:113533. doi:10.1016/j.physbeh.2021.113533
   PubMed Web of Science ®Google Scholar
• Hughes CE, Nibbs RJB. A guide to chemokines and their receptors. FEBS J. 2018;285(16):2944–2971. doi:10.1111/febs.14466
   PubMed Web of Science ®Google Scholar
• Bettcher BM, Fitch R, Wynn MJ, et al. MCP-1 and eotaxin-1 selectively and negatively associate with memory in MCI and Alzheimer’s disease dementia phenotypes. Alzheimers Dement. 2016;3:91–97.
   Google Scholar
• Morgan AR, Touchard S, Leckey C, et al. Inflammatory biomarkers in Alzheimer’s disease plasma. Alzheimers Dement. 2019;15(6):776–787. doi:10.1016/j.jalz.2019.03.007
   PubMed Web of Science ®Google Scholar
• Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354(6):610–621. doi:10.1056/NEJMra052723
   PubMed Web of Science ®Google Scholar
• Marksteiner J, Kemmler G, Weiss EM, et al. Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging. 2011;32(3):539–540. doi:10.1016/j.neurobiolaging.2009.03.011
   PubMed Web of Science ®Google Scholar
• Bayer AJ. The role of biomarkers and imaging in the clinical diagnosis of dementia. Age Ageing. 2018;47(5):641–643. doi:10.1093/ageing/afy004
   PubMed Web of Science ®Google Scholar